Skip to main content

Table 2 Multivariate analysis of thrombotic risk in current cohort

From: Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study

Variants

VTE

 

First-onset of VTE

 

Recurrent VTE

Adjusted OR(95%CI)

P value

 

Adjusted OR(95%CI)

P value

 

Adjusted OR(95%CI)

P value

Gender

0.987 (0.699–1.396)

0.943

 

0.812 (0.536–1.229)

0.325

 

2.491 (1.586–3.913)

7.40 × 10− 5

Age

1.021 (1.009–1.033)

7.71 × 10− 4

 

/

/

 

1.038 (1.023–1.054)

4.56 × 10− 7

PC R189W

5.781 (1.501–22.262)

0.011

 

0.986 (0.425–2.288)

0.974

 

0.971 (0.405–2.330)

0.947

PC K193del

4.365 (1.743–10.931)

0.002

 

0.867 (0.451–1.670)

0.670

 

1.804 (0.923–3.526)

0.085

Rare PC mutations

84.479 (11.499–620.654)

1.30 × 10− 5

 

0.623 (0.374–1.038)

0.069

 

1.892 (1.103–3.246)

0.020

PS mutations

79.009 (19.111–326.631)

1.60 × 10− 9

 

0.463 (0.289–0.743)

0.001

 

2.112 (1.256–3.553)

0.005

AT mutations

61.318 (8.258–455.326)

5.70 × 10− 5

 

0.445 (0.232–0.851)

0.014

 

3.415 (1.723–6.769)

4.33 × 10− 4

Other genetic mutations

2.35 × 109

0.998

 

0.454 (0.171–1.205)

0.113

 

4.556 (1.656–12.533)

0.003

Acquired risk factors

18.273 (8.516–39.210)

8.77 × 10− 14

 

0.375 (0.241–0.584)

1.40 × 10− 5

 

2.107 (1.300–3.414)

0.002

Positive family history

/

/

 

1.365 (0.752–2.477)

0.307

 

1.731 (0.939–3.193)

0.079

  1. AT, antithrombin; CI, confidence interval; OR, odds ratio; PC, protein C; PS, protein S; VTE, venous thromboembolism; P value < 0.05, significant difference